GAMBLE JONES INVESTMENT COUNSEL - ZIOPHARM ONCOLOGY INC ownership

ZIOPHARM ONCOLOGY INC's ticker is ZIOP and the CUSIP is 98973P101. A total of 159 filers reported holding ZIOPHARM ONCOLOGY INC in Q3 2020. The put-call ratio across all filers is 1.22 and the average weighting 0.1%.

Quarter-by-quarter ownership
GAMBLE JONES INVESTMENT COUNSEL ownership history of ZIOPHARM ONCOLOGY INC
ValueSharesWeighting
Q4 2022$39,595
-62.3%
61,0000.0%0.00%
-66.7%
Q3 2022$105,000
+38.2%
61,0000.0%0.01%
+50.0%
Q2 2022$76,000
+90.0%
61,0000.0%0.01%
+200.0%
Q1 2022$40,000
-39.4%
61,0000.0%0.00%
-50.0%
Q4 2021$66,000
+17.9%
61,000
+96.8%
0.00%0.0%
Q3 2021$56,000
-31.7%
31,0000.0%0.00%
-20.0%
Q2 2021$82,000
-26.8%
31,0000.0%0.01%
-37.5%
Q1 2021$112,000
+43.6%
31,0000.0%0.01%
+60.0%
Q4 2020$78,0000.0%31,0000.0%0.01%
-16.7%
Q3 2020$78,000
-23.5%
31,0000.0%0.01%
-25.0%
Q2 2020$102,000
+37.8%
31,000
+3.3%
0.01%
+14.3%
Q1 2020$74,000
-43.9%
30,000
+7.1%
0.01%
-30.0%
Q4 2019$132,000
+10.0%
28,0000.0%0.01%0.0%
Q3 2019$120,000
-26.4%
28,0000.0%0.01%
-28.6%
Q2 2019$163,000
+40.5%
28,000
-6.7%
0.01%
+40.0%
Q1 2019$116,000
+107.1%
30,0000.0%0.01%
+66.7%
Q4 2018$56,00030,0000.01%
Other shareholders
ZIOPHARM ONCOLOGY INC shareholders Q3 2020
NameSharesValueWeighting ↓
Third Security, LLC 9,709,607$51,946,0002.80%
MILLER VALUE PARTNERS, LLC 4,900,721$26,219,0001.15%
MSD Partners, L.P. 3,410,500$18,246,0000.92%
Michael & Susan Dell Foundation 66,749$357,0000.26%
Glacier Peak Capital LLC 68,043$364,0000.21%
Vident Investment Advisory, LLC 114,980$615,0000.08%
SFMG, LLC 62,433$334,0000.07%
Virtus ETF Advisers LLC 40,359$216,0000.06%
Steward Partners Investment Advisory, LLC 23,187$124,0000.06%
O'Dell Group, LLC 10,142$54,0000.05%
View complete list of ZIOPHARM ONCOLOGY INC shareholders